Veerhealth Care Ltd strategy deck summary

Strategy deck of 25 Feb 2026, summarised by AI from the filing.

Veerhealth Care reports Q3 FY26 revenue of ₹725.79 lakh and projects Net Sales of ₹9,715.40 lakh by FY 2027-28.

Key takeaways

1. Q3 FY26 revenue Revenue from operations ₹725.79 lakh (Q2 FY26: ₹398.00 lakh; Q3 FY25: ₹383.89 lakh).
2. Net Sales projection Net Sales projected at ₹3,010.03 lakh (FY 2025-26), ₹5,850.78 lakh (FY 2026-27), ₹9,715.40 lakh (FY 2027-28).
3. USFDA approval Received USFDA approval for products registered under Drug (OTC) in June 2025.
4. New FMCG client Recently onboarded a leading FMCG company in personal and household care segment, part of a 125 year old business group.
5. Forward-looking risks Forward-looking statements are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict.

Original filing on BSE

Veerhealth Care Ltd earnings call, investor presentation and press release summaries

• Q4 FY26: Results press release (2 Jun 2026)
• Q3 FY26: Results press release (16 Feb 2026)
• Q1 FY26: Results press release (13 Aug 2025)
• Other events: Strategy deck (27 Jun 2026), Strategy deck (25 Feb 2026)